Abstract:Importance Aortic stenosis (AS) is a major public health challenge with a growing therapeutic landscape, but current biomarkers do not inform personalized screening and follow-up. A video-based artificial intelligence (AI) biomarker (Digital AS Severity index [DASSi]) can detect severe AS using single-view long-axis echocardiography without Doppler characterization. Objective To deploy DASSi to patients with no AS or with mild or moderate AS at baseline to identify AS development and progression. Design, Setting, and Participants This is a cohort study that examined 2 cohorts of patients without severe AS undergoing echocardiography in the Yale New Haven Health System (YNHHS; 2015-2021) and Cedars-Sinai Medical Center (CSMC; 2018-2019). A novel computational pipeline for the cross-modal translation of DASSi into cardiac magnetic resonance (CMR) imaging was further developed in the UK Biobank. Analyses were performed between August 2023 and February 2024. Exposure DASSi (range, 0-1) derived from AI applied to echocardiography and CMR videos. Main Outcomes and Measures Annualized change in peak aortic valve velocity (AV-V max ) and late (&gt;6 months) aortic valve replacement (AVR). Results A total of 12 599 participants were included in the echocardiographic study (YNHHS: n = 8798; median [IQR] age, 71 [60-80] years; 4250 [48.3%] women; median [IQR] follow-up, 4.1 [2.4-5.4] years; and CSMC: n = 3801; median [IQR] age, 67 [54-78] years; 1685 [44.3%] women; median [IQR] follow-up, 3.4 [2.8-3.9] years). Higher baseline DASSi was associated with faster progression in AV-V max (per 0.1 DASSi increment: YNHHS, 0.033 m/s per year [95% CI, 0.028-0.038] among 5483 participants; CSMC, 0.082 m/s per year [95% CI, 0.053-0.111] among 1292 participants), with values of 0.2 or greater associated with a 4- to 5-fold higher AVR risk than values less than 0.2 (YNHHS: 715 events; adjusted hazard ratio [HR], 4.97 [95% CI, 2.71-5.82]; CSMC: 56 events; adjusted HR, 4.04 [95% CI, 0.92-17.70]), independent of age, sex, race, ethnicity, ejection fraction, and AV-V max . This was reproduced across 45 474 participants (median [IQR] age, 65 [59-71] years; 23 559 [51.8%] women; median [IQR] follow-up, 2.5 [1.6-3.9] years) undergoing CMR imaging in the UK Biobank (for participants with DASSi ≥0.2 vs those with DASSi &lt;.02, adjusted HR, 11.38 [95% CI, 2.56-50.57]). Saliency maps and phenome-wide association studies supported associations with cardiac structure and function and traditional cardiovascular risk factors. Conclusions and Relevance In this cohort study of patients without severe AS undergoing echocardiography or CMR imaging, a new AI-based video biomarker was independently associated with AS development and progression, enabling opportunistic risk stratification across cardiovascular imaging modalities as well as potential application on handheld devices.

Deep Learning Model of Diastolic Dysfunction Risk Stratifies the Progression of Early-Stage Aortic Stenosis

A Deep Patient-Similarity Learning Framework for the Assessment of Diastolic Dysfunction in Elderly Patients

Artificial intelligence-enabled predictive model of progression from moderate to severe aortic stenosis

AI-Enhanced Prediction of Aortic Stenosis Progression: Insights From the PROGRESSA Study

A machine learning-derived risk score to predict left ventricular diastolic dysfunction from clinical cardiovascular magnetic resonance imaging

An Artificial Intelligence Algorithm for Detection of Severe Aortic Stenosis: A Clinical Cohort Study

Early Detection of Left Ventricular Dysfunction With Machine Learning‐Based Strain Imaging in Aortic Stenosis Patients

Multi-modality deep learning model for prediction of chronic obstructive coronary artery disease

A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression

Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis

Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis

Deep learning approach for analyzing chest x-rays to predict cardiac events in heart failure

Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning

Deep learning-based coronary computed tomography analysis to predict functionally significant coronary artery stenosis

Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes

Prospective clinical evaluation of deep learning for ultrasonographic screening of abdominal aortic aneurysms

Revealing unforeseen diagnostic image features with deep learning by detecting cardiovascular diseases from apical four-chamber ultrasounds

Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease

Understanding Complex Interactions in Pediatric Diastolic Function Assessment

Deep learning analysis of resting electrocardiograms for the detection of myocardial dysfunction, hypertrophy, and ischaemia: a systematic review

Machine learning-based risk stratification for mortality in patients with severe aortic regurgitation